Page 38 - Vaccination

GST panel rejects demand for tax waiver on Covid-19 vax, ventilator

GST fitment panel has recommended a short-term rate cut on four Covid-19 related items

Total Covid-19 vaccine doses administered in India crosses 20 crore

In a significant landmark, the cumulative COVID-19 vaccine doses administered in the country has crossed 20 crore, the Union health ministry said on Tuesday.

Over 1.77 cr doses of vaccines still available with states, UTs: Health Min

More than 1.77 crore doses of anti-coronavirus vaccines are still available with the states and Union Territories, while seven lakh doses are in the pipeline, Union Health Ministry said

Delhi yet to receive more Covid-19 vaccines for 18-44 group, says Atishi

Delhi is yet to receive more vaccines for the 18-44 age group and only private hospitals are giving jabs to beneficiaries in this category for now, Aam Aadmi Party MLA Atishi said on Tuesday

Best of BS Opinion: Going viral on vaccines, another data breach & more

Here are the best of Business Standard's opinion pieces for Tuesday

Oh for a simpler world?

Well, never underestimate this country and how badly or well something may be managed unless you experience it for yourself

Covid-19 crisis: In rural Thane, fresh cases down but fatalities still high

The fourth part of the series looks at the Covid situation in parts of Maharashtra's rural Thane district

Covid vaccination: Walk-ins allowed for 18-44 age bracket at govt centres

Private centres have to continue publishing their vaccination schedule in advance for online appo­in­tments

Centre steps in after foreign Covid-19 vaccine makers say no to state govts

Union govt in direct talks with firms but order book full for now

WHO seeks more details from Bharat Bio for emergency use listing of Covaxin

The World Health Organisation (WHO) said more information is required from Bharat Biotech, which is seeking emergency use listing (EUL) for its Covaxin vaccine for COVID-19. The latest Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process' guidance document dated May 18 on the WHO website said Bharat Biotech submitted EOI (Expression of Interest) on April 19 and that More information required. A pre-submission meeting is expected to be planned May-June 2021, the guidance document said. According to the WHO, submissions to it for prequalification or listing under the emergency use procedure are confidential. If a product submitted for assessment is found to meet the criteria for listing, WHO will publish the results widely. Duration of the emergency use listing process depends on the quality of the data submitted by the vaccine manufacturer and on those data meeting WHO criteria, according to the agency. Meanwhile, Bharat Biotech International Limited (BBIL) has conveyed

Going viral on vaccines

A sustained publicity campaign is urgently needed

Countries must vaccinate 10% of their population by Sept, says WHO

French President Emmanuel Macron called for the WHO to be empowered to visit countries rapidly in case of outbreaks with potential to spark a pandemic

Best of BS Opinion: A recovery interrupted, RBI's disclosure dilemma & more

Here are the best of Business Standard's opinion pieces for Monday

Rural pulse: In long queue for vax after a relentless second Covid-19 wave

The third part of the series looks at the state of vaccination in parts of rural Bengal

US investigating heart problem in a few young Covid-19 vaccine recipients

There were 'relatively few' cases and they may be entirely unrelated to the jab

Focus on the pandemic, not the economy

The big lesson of the second wave is that India must stop trying to prioritise economic recovery over emergence from the pandemic - any such effort is destined to fail

Maharashtra to start 24-hour Covid vaccination drive: CM Uddhav Thackeray

Covid-19 vaccination for persons between 18-45 years began from May 1 throughout the nation and is being funded by state governments

64,000 people got Covid-19 vaccine jabs in Delhi on May 22: AAP MLA

Around 64,000 people received Covid-19 vaccine jabs in Delhi on May 22, AAP MLA Atishi said on Sunday

Covid: Moderna CEO advocates 3rd vaccine dose to protect people at risk

Vaccination with a booster shot among as many people as possible is a good way to protect those most at risk against ever-emerging new coronavirus variants, says Moderna CEO Stephane Bancel

Serum Institute disassociates from executive's remarks on Covid vaccination

Serum Institute has disassociated itself from its executive director's statement that govt began the Covid vaccination of multiple age groups without taking into consideration the available stock